logo
Select company
Select metric
1.12Cash Ratio
VS
Market
70
Sector
46
Industry
31
History
10
$ 5.29Close
$ 2.73 - $ 8.07 52-Week Range
Ticker Information

Ticker

VYGR

Company Name

VOYAGER THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

VOYAGER THERAPEUTICS INC - Cash Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

VYGR - Cash Ratio Historical data
DateCash and EquivalentsCash RatioCurrent Liabilities
6/30/2025$ 46.81M1.12$ 41.98M
3/31/2025$ 77.63M1.93$ 40.21M
12/31/2024$ 74.24M1.49$ 49.79M
9/30/2024$ 112.53M2.55$ 44.21M
6/30/2024$ 76.13M1.9$ 40.13M
3/31/2024$ 143.08M1.97$ 72.55M
12/31/2023$ 68.8M1.07$ 64.51M
9/30/2023$ 65.27M1.06$ 61.69M
6/30/2023$ 244.29M5.38$ 45.4M
3/31/2023$ 268.32M13.46$ 19.94M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • VOYAGER THERAPEUTICS INC's latest trailing twelve months (TTM) Cash Ratio stands at 3.51.
  • Over the past 5 years, VOYAGER THERAPEUTICS INC's average Cash Ratio has been 3.01.
  • The median Cash Ratio for VOYAGER THERAPEUTICS INC during this period was 1.95
  • VOYAGER THERAPEUTICS INC reached its highest Cash Ratio over the past 5 years at 13.46.
  • The lowest Cash Ratio recorded by VOYAGER THERAPEUTICS INC in the same timeframe 0.8

VOYAGER THERAPEUTICS INC's Cash Ratio vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash Ratio Benchmarks
CompanyCash Ratio
CCCC : C4 THERAPEUTICS INC 1.84FENC : FENNEC PHARMACEUTICALS INC 2.22EDIT : EDITAS MEDICINE INC 2.1OABI : OMNIAB INC 1.49FHTX : FOGHORN THERAPEUTICS INC 0.97MGX : METAGENOMI INC 0.96ICCC : IMMUCELL CORP 1.35TLSI : TRISALUS LIFE SCIENCES INC 2.84SEER : SEER INC 3.26SPRO : SPERO THERAPEUTICS INC 2.09

Definition of Cash Ratio

[Calculation] The Cash Ratio is a liquidity indicator that describes a company's ability to meet short-term obligations with cash and cash equivalents. Calculated by dividing cash and cash equivalents [CashnEq] by current liabilities [LiabilitiesC].
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for VOYAGER THERAPEUTICS INC is calculated as follows: CashnEq [ $ 147.45M ] / LiabilitesC [ $ 42.05M ]
(=) Cash Ratio [ 3.51 ]

VYGR - Cash Ratio, Last 5 years

0.8

Minimum

Jun 30, 2022

13.46

Maximum

Mar 31, 2023

3.01

Average

1.95

Median

Cash Ratio Benchmark Analysis

The chart above depicts the distribution of Cash Ratio for companies in the Total Stock Market. The average Cash Ratio of the companies is 0.62 with a standard deviation of 0.63.
The following table provides additional summary stats:
Cash Ratio in the Market:
filtered constituents3.13K
min0
max2.69
average0.62
median0.39
std0.63